Skip to content
NCRI logo alt test Toggle Menu

Main Navigation

  • About us
    • Overview
    • Our Partners
    • Our Team
    • Our Trustees
    • Our Strategy
    • Jobs and Opportunities
  • How We Work
    • Pathology
    • Radiotherapy
    • Research Groups
    • Proposals Guidance
    • Clinical Trials Units
    • Patients and Carers
    • Cancer Research Database
  • Areas of Interest
    • Health Data and AI
    • Prevention and Early Diagnosis
    • Immunotherapy and Immunology
    • Living with and Beyond Cancer
    • Imaging
    • Clinical Research Delivery
    • Training and Retention
  • News and Events
    • News
    • Events
    • Reports and Publications
Newsletter sign up

Prostate

Filter Posts By:

  • Areas of Interest
    • Cancer Research Funding
    • Clinical Research Delivery
    • Health Data and AI
    • Imaging
    • Immunotherapy & Immunology
    • Living With & Beyond Cancer
    • Pathology
    • Patient & Public Involvement
    • Prevention & Early Diagnosis
    • Radiotherapy
    • Training & Retention
  • Cancers
    • Bladder & Renal
    • Brain
    • Breast
    • Children
    • Colorectal
    • Gynaecological
    • Haematological
    • Head & Neck
    • Lung
    • Lymphoma
    • Prostate
    • Sarcoma
    • Skin
    • TYA
    • Upper Gastrointestinal
  • Content
    • Blog
    • Case Study
    • Interviews
    • News
    • Press Releases

Reset Filters

'

Using knowledge provided by NCRI research funding data to increase the impact of prostate cancer research

'
16 November 2020

Prostate Cancer Research recognised that with a large number of cancer research charities duplication was a possibility and that challenges…

Read More

'

Accurate detection of prostate cancer and the crucial role of patient involvement

'
27 May 2020

The Prostagram trial investigated the use of MRI scans to detect prostate cancer. At present, there is no nationally approved…

Read More

'

Quick and efficient testing of prostate cancer treatments, changing trial design and clinical practice

'
10 February 2020

Lack of treatments and evidence As recently as ten years ago, despite many new drugs being approved for use in…

Read More

'

Reducing the number of prostate biopsies by improving diagnosis

'
10 February 2020

Addressing problems with prostate cancer diagnosis To diagnose prostate cancer, PSA (prostate specific antigen) levels in the blood are used…

Read More

'

Reducing the prostate cancer treatment burden on both patients and the health service

'
10 February 2020

Radiotherapy treatment for prostate cancer Standard radiotherapy for prostate cancer is an important and effective treatment, but until recently involved…

Read More

'

High levels of two hormones in the blood raise prostate cancer risk

'
01 November 2019

Men with higher levels of ‘free’ testosterone and a growth hormone in their blood are more likely to be diagnosed…

Read More

'

Men with prostate cancer are willing to accept lower survival odds to side effects

'
05 November 2018

Men who have been newly diagnosed with prostate cancer say they would trade some improvement in their odds of survival…

Read More

'

Low testosterone levels linked to reduced risk of prostate cancer

'
04 November 2017

Men with unusually low amounts of testosterone in their blood are around 20% less likely to develop prostate cancer, according…

Read More

'

Marker for aggressive prostate cancer doubles-up as a drug target

'
09 November 2016

Researchers have discovered that a marker found on aggressive prostate cancer cells could also be used as a way to…

Read More

'

Tumour cells in blood samples could predict prostate cancer spread

'
04 November 2016

Researchers have found a group of circulating tumour cells in prostate cancer patient blood samples which are linked to the…

Read More

'

Prostate cancer test can spot the difference between aggressive and slow-growing tumours

'
05 November 2013

A NEW test may overcome one of the biggest problems in prostate cancer treatment – telling slow-growing tumours from aggressive…

Read More

'

Personalised prostate cancer screening may save thousands from unnecessary treatment

'
05 November 2012

TARGETING prostate cancer screening based on a man’s age and genes could potentially save thousands of men from unnecessary treatment…

Read More

Posts navigation

  • 1
  • 2
  • »

National Cancer Research Institute (NCRI)

2 Redman Place London E20 1JQ
T: +44 (0)20 3469 8798
E: info@ncri.org.uk

NCRI is a Charitable Incorporated Organisation (registered charity number: 1160609)

  • Terms and Conditions
  • Privacy Policy
  • Newsletter